1. Identify the product precisely
Name the medicine by its International Nonproprietary Name (INN), the unique name for its active substance that WHO describes as recognised globally and public property. Then add everything that makes your order exact:
- INN, and the brand name if you need a specific originator brand
- Strength and dosage form, for example tablet, vial or prefilled syringe
- Pack size and the quantity you need
- Whether a generic or a biosimilar is acceptable instead of the brand
2. Confirm the import route in your country
How a medicine may enter your country depends on its status there. The common routes are:
- Registered product. The medicine holds a marketing authorisation in your country and a licensed importer brings it in.
- Named patient or special access. The medicine is not registered, and a doctor or hospital obtains it for an individual patient through a route your regulator allows. See our guide to named patient supply and special access.
- Tender or programme supply. A government tender or an NGO programme sets its own product and document requirements.
- Clinical trial. Comparator medicines follow the trial's own authorisation.
For every enquiry, Bio Bridge Pharma confirms the registration route and the import licence needed in your destination before making an offer.
3. Check your import licence or permit
The importing organisation usually needs its own licence or permit from its national regulator, and some routes need approval for each consignment. Two examples from official guidance:
- Singapore's Health Sciences Authority asks importers using its special access routes to hold an importer's licence and a wholesaler's licence before import, and to obtain approval for each consignment.
- Health Canada notes that a Canadian importer pre-positioning drugs under its Special Access Program must hold an establishment licence in Canada.
Requirements differ from country to country, so confirm yours with your regulator and share the details with your supplier.
4. Agree the documents you need
Ask for the documents your regulator and customs authority will check, before the order is placed:
- Certificate of analysis for the batch: WHO's model lists the tests performed, the results and the acceptance criteria, and it is usually prepared for each batch.
- Certificate of Pharmaceutical Product (CoPP) where your regulator asks for one. Read what a CoPP confirms.
- Commercial invoice and packing list for customs clearance.
- Your import licence or permit, and any approval issued for the consignment.
- Temperature records for refrigerated products.
5. Plan for temperature-sensitive products
WHO describes time- and temperature-sensitive products as goods that can degrade so that they no longer perform as intended if they are not stored or transported within set conditions. For refrigerated medicines, ask how the packaging keeps the product within its range for the journey, how temperature is monitored in transit and how the readings are checked on arrival. Our cold-chain guide lists the questions to ask.
6. Agree delivery terms
The International Chamber of Commerce publishes the Incoterms rules, standards used in contracts for the delivery of goods. Agree which Incoterms rule applies to your order, so it is clear who arranges each part of the journey and the customs clearance.
7. Check the shipment on arrival
Compare the goods with the documents: product, strength, batch numbers, expiry dates and quantities. For refrigerated products, review the temperature indicator or logger on arrival and keep the record. WHO's distribution guidance asks for distribution records detailed enough to allow a recall when required.
- Product (INN or brand), strength, dosage form and pack size
- Quantity and destination country
- Your organisation type: hospital, importer, distributor, tender buyer or trial team
- Import licence or permit details, if you have them
- The documents your regulator requires
Sources
- World Health Organization, International Nonproprietary Names: who.int/teams/health-product-and-policy-standards/inn
- Health Sciences Authority, Singapore, import for patients (special access routes): hsa.gov.sg
- Health Canada, Special Access Program for drugs: canada.ca
- World Health Organization, Model certificate of analysis (Technical Report Series 1010, Annex 4): who.int (PDF)
- World Health Organization, Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products (Technical Report Series 961, Annex 9): who.int
- International Chamber of Commerce, Incoterms rules: iccwbo.org
- World Health Organization, Good storage and distribution practices for medical products (Technical Report Series 1025, Annex 7): who.int